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Abstract:  1 
Objectives: People with Parkinson’s disease (PD) are at higher risk of malnutrition due to 2 
PD symptoms and pharmacotherapy side effects. When pharmacotherapy is no longer 3 
effective for symptom control, deep-brain stimulation (DBS) surgery may be considered. The 4 
aim of this study was to assess the nutritional status of people with PD who may be at higher 5 
risk of malnutrition related to unsatisfactory symptom management with optimised medical 6 
therapy. Design: This was an observational study using a convenience sample. Setting: 7 
Participants were seen during their hospital admission for their deep brain stimulation 8 
surgery. Participants: People with PD scheduled for DBS surgery were recruited from a 9 
Brisbane neurological clinic (n=15). Measurements: The Patient-Generated Subjective 10 
Global Assessment (PG-SGA), weight, height and body composition were assessed to 11 
determine nutritional status. Results: Six participants (40%) were classified as moderately 12 
malnourished (SGA-B). Eight participants (53%) reported previous unintentional weight loss 13 
(average loss of 13.3%). On average, participants classified as well-nourished (SGA-A) were 14 
younger, had shorter disease durations, lower PG-SGA scores, higher body mass (BMI) and 15 
fat free mass indices (FFMI) when compared to malnourished participants (SGA-B). Five 16 
participants had previously received dietetic advice but only one in relation to 17 
unintentional weight loss. Conclusion: Malnutrition remains unrecognised and untreated 18 
in this group despite unintentional weight loss and presence of nutrition impact symptoms. 19 
Improving nutritional status prior to surgery may improve surgical outcomes. 20 
 21 
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Background: 1 
Malnutrition, or protein-energy under-nutrition, is associated with lower quality of life and 2 
poorer health outcomes.(1–3) Significantly lower body weight and body mass indices 3 
(BMI)(4) and higher rates of unintentional weight loss(5,9) have been found in people with 4 
Parkinson’s disease (PD) compared to age-matched controls. More severe disease 5 
symptoms may result in higher amounts of weight loss and a greater risk of 6 
malnutrition.(5,7,9)  7 
The clinical motor characteristics of PD can impair functional ability,(10) result in an inability 8 
to shop, cook, and feed independently and increase the risk of malnutrition.(11) Many PD 9 
non-motor symptoms have been found to contribute to decreased food intake and 10 
subsequent weight loss in the elderly and in PD.(9,12,13)  11 
Side effects of anti-parkinsonian medication include nausea, vomiting and weight loss. 12 
Higher intakes of levodopa have been associated with lower BMIs(15) as well as ‘off’ periods 13 
which are associated with prolonged levodopa use resulting in more pronounced PD 14 
symptoms.(16) Levodopa-induced dyskinesias can further impair function(17) and increase 15 
energy expenditure.(18,19)  16 
When medical therapy is no longer effectively controlling PD symptoms, deep-brain 17 
stimulation (DBS) surgery may be considered.(20) Uncontrolled symptoms and the side 18 
effects of increased medication, present in patients eligible for DBS surgery, may further 19 
increase the risk of malnutrition in this group. 20 
Therefore, the aim of this pilot study was to assess the nutritional status of people with PD 21 
who may be at higher risk of malnutrition related to unsatisfactory symptom management 22 
with optimised medical therapy. 23 
Methods: 24 
Twenty community-dwelling patients clinically diagnosed with idiopathic PD and scheduled 25 
for bilateral subthalamic nucleus deep-brain stimulation surgery (STN-DBS) between 30 26 
March and 2 June 2010 were contacted from a neurology clinic in Queensland, Australia 27 
resulting in a convenience sample of 18 participants. Informed written consent was obtained 28 
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as per protocol approved by the UnitingCare Health and Queensland University of 1 
Technology Human Research Ethics Committees. 2 
Questionnaires, including demographics information; current medications; the Scale for 3 
Outcomes of Parkinson’s disease–Autonomic (SCOPA-AUT)(21) and Modified Constipation 4 
Assessment Scale (MCAS),(22) were completed prior to the data collection visit.  5 
Participants were interviewed either prior to or during hospital admission. The Patient-6 
Generated Subjective Global Assessment (PG-SGA)(23) was performed by a dietitian to 7 
assess nutritional status. The PG-SGA is a nutrition assessment tool previously used to 8 
assess nutritional status in community-dwelling elderly,(24) oncology patients,(25) and 9 
patients with chronic kidney disease.(26) The PG-SGA consists of a medical history (recent 10 
changes in weight, nutrition impact symptoms (lack of appetite, nausea/vomiting, changes in 11 
smell and taste, constipation, dry mouth, mouth sores, early satiety, pain, difficulties 12 
swallowing),, food intake, functional capacity, components of metabolic stress) and physical 13 
examination of fat and muscle stores. A number of the nutrition impact factors included in the 14 
PG-SGA, such as nausea, pain, lack of appetite, dysphagia, changes in smell and taste and 15 
constipation are also symptoms associated with PD. The PG-SGA provides an additive 16 
score with a higher score indicating a greater risk of malnutrition. It also includes the 17 
Subjective Global Assessment (SGA), a global rating of nutritional status, categorising 18 
patients as SGA-A (well nourished), SGA-B (moderately malnourished) or SGA-C (severely 19 
malnourished). 20 
Body weight was measured to the nearest 0.1kg (Tanita HD-316, Japan) in light clothing, 21 
without shoes. All participants were able to stand independently; therefore standing height 22 
was measured to the nearest 0.1cm, without shoes. BMI was calculated (body 23 
weight(kg)/(height in metres)2). Mid-arm circumference (MAC) was measured at the mid-24 
point between the acromion and the olecranon process on the non-dominant arm. Waist 25 
circumference was measured at the mid-point between the iliac crest and the lower rib.  26 
Body composition was assessed using bioelectrical impedance spectroscopy (BIS) 27 
(ImpediMed Imp SFB7, Brisbane, Australia) after removing all metal objects and lying supine 28 
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for at least 5 minutes. The measurements were taken in the bioimpedance spectroscopy 1 
mode over a range of 4-1000 kHz, and the estimates of fat and fat free mass (kg, %) 2 
provided by the ImpediMed were used. Fat free mass index (FFMI) was calculated as fat 3 
mass(kg)/((height in metres)2). 4 
The WHO BMI categories were initially used to classify participants as underweight 5 
(BMI<18.5kg/m2), normal weight (BMI 18.5-24.99kg/m2) and overweight/obese (BMI 6 
>25.0kg/m2). Participants were then categorised by BMI according to age. Participants 7 
younger than 65 years of age were classified according to the WHO BMI categories. 8 
Participants aged 65 years and older were classified as underweight with BMI <23.5kg/m2, 9 
normal weight with BMI 23.5–27.5kg/m2, and overweight/obese with BMI >27.5kg/m2.(27) 10 
Statistical analysis was completed using SPSS Version 17 (SPSS Inc., Chicago, IL, USA). 11 
Variables were compared between SGA-A and SGA-B classifications only as no one was 12 
classified as SGA-C.  Non-parametric Mann Whitney U tests were used to assess 13 
differences between groups due to the small sample size. Therefore all values are reported 14 
as median (range). Statistical significance was set at p<0.05. 15 
 16 
Results: 17 
Eighteen of the twenty PD patients eligible agreed to participate but subsequently, 2 18 
withdrew due to anxiety relating to the procedure and 1 person withdrew due to spousal 19 
disapproval of research projects. Median age of the fifteen participants (11 male) was 68.0 20 
years (range 42.0-78.0). Self-reported average length of disease was 6.75 (range 0.5 – 24.0) 21 
years while self-reported length of time since symptom onset was 10.0 (range 2.0 – 30.0) 22 
years. 23 
Using the World Health Organisation (WHO) BMI cut-offs, none of the participants were 24 
classified as underweight. Nine were in the normal weight range, four were overweight, and 25 
two were obese. Using the age-specific categories, five were underweight, six were in the 26 
normal weight range, and four were overweight or obese. Five participants (33%) had 27 
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previously received dietetic advice from a dietitian or nutritionist: only one for unintentional 1 
weight loss. 2 
Eight participants (53%) reported unintentional weight loss since PD diagnosis (Table 1) for 3 
an average 13% (range: 4–24%) of original body weight lost. Those who lost weight 4 
unintentionally were significantly older, (U=5.5,z=-2.62,p<.01) and had significantly lower 5 
BMIs, (U=4.0,z=-2.78,p<.01) and MACs, (U=2.0,z=-2.88,p<.01), than those who did not 6 
report losing weight unintentionally. Differences between the groups are reported in Table 1. 7 
The median waist circumference, fat free mass index (FFMI), SCOPA-AUT and MCAS 8 
scores were also lower in those with unintentional weight loss, but this did not reach 9 
significance. All of those with unintentional weight loss had BMIs that fell within the healthy 10 
weight range according to the WHO. 11 
Six participants (40%) were classified as moderately malnourished (SGA-B) (Table 1). There 12 
were no significant differences between the two groups (SGA-A and SGA-B) in any of the 13 
characteristics analysed. BMIs for the SGA-B group were significantly lower than those for 14 
the SGA-A group, (U=10.5,z=-1.95,p=.05). The SGA-B group had a median BMI within the 15 
WHO healthy weight range, and the SGA-A group had a median BMI within the WHO 16 
overweight range. This difference bordered on significance (p=.052). According to the age-17 
specific categories, two of the SGA-A participants (22%) had BMIs in the underweight range, 18 
three (33%) were in the normal weight range, and four (44%) were overweight or obese 19 
while three of the SGA-B participants (50%) had BMIs in the underweight range and another 20 
three (50%) had BMIs in the normal weight range. Participants classified as SGA-A had 21 
larger mid-arm circumferences (MAC) and waist circumferences, higher median FFMI and 22 
lower PG-SGA scores than the SGA-B group. The SGA-A participants reported better bowel 23 
function on the MCAS than the SGA-B participants.  24 
Of the nutrition impact symptoms listed on the PG-SGA, 12 of the participants listed at least 25 
one as affecting their food intake over the previous 2 weeks. Seven (58%) listed 26 
constipation. Early satiety, things tasting funny or having no taste, dry mouth and problems 27 
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swallowing each affected 3 (25%) people while lack of appetite, diarrhoea, nausea, and lack 1 
of smell each affected 2 (17%) people.  2 
Discussion 3 
A higher percentage of the current sample in the current study was malnourished according 4 
to SGA classification than has been previously reported in people with PD when classified 5 
using a nutrition assessment tool.(28,29) In addition, the majority reported previous clinically 6 
significant unintentional weight loss resulting in significantly lower nutritional status 7 
parameters.  8 
Protein-energy malnutrition is associated with a lower quality of life and poorer health 9 
outcomes. Our results demonstrate that the prevalence of malnutrition in this group is high 10 
with 40% of the participants classified as malnourished. Comparatively, on an international 11 
level, the prevalence of malnutrition in community-dwelling older adults is 3-11%(24,30,31)  12 
while the prevalence of malnutrition in Parkinson’s disease has been reported to be between 13 
0-2%.(28,29) In addition, in the current study, 53% of the participants reported significant 14 
amounts of weight loss since diagnosis. In a previous study by Abbott, et al (1992)(6), 52% 15 
of participants reported experiencing unintentional weight loss, similar to the percentage 16 
found in the current study, nearly 20 years later. As with other at-risk groups, malnutrition 17 
remains under-recognised and untreated in people with PD despite the fact that 18 
unintentional weight loss and low body weights have been reported for decades.  19 
The increasing global prevalence of overweight and obesity may contribute to the lack of 20 
recognition of malnutrition. Historically BMI has been the tool of choice to identify health risks 21 
based on body weight. BMI is a measure of body size or mass and alone is not sensitive 22 
enough to recognise small yet clinically-significant weight loss(33) where the weight loss 23 
may result in significant loss of lean body mass but does not result in a BMI classification 24 
change. People can be at risk of malnutrition or malnourished and be classified as 25 
overweight or obese according to BMI (sarcopenic obesity). Nor can BMI detect changes in 26 
nutrition impact symptoms which may lead to weight loss. Therefore, it is important to take 27 
into account recent weight loss, loss of appetite and changes in eating habits when 28 
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identifying someone at risk of malnutrition. The PG-SGA as a nutrition assessment tool does 1 
take into account weight loss, changes in food intake and functional status. It also captures 2 
the nutrition impact symptoms that are present in Parkinson’s disease such as nausea, pain, 3 
lack of appetite, dysphagia, changes in smell and taste and constipation. 4 
Research to date has focused on how DBS affects weight post-surgery, particularly weight 5 
gain. This is the first study to report nutritional status prior to undergoing DBS. Not 6 
surprisingly, the rate of malnutrition in this group is higher than that reported previously (0-7 
2%)(28,29) for people with PD; however, given the small sample size, this may not 8 
generalise to the entire PD population eligible for DBS. This could also be due to the fact 9 
that different nutrition assessment tools have been used.  10 
Also, due to the small sample size, statistically significant differences between the groups 11 
could not be established despite the fact that trends were identified. If a similar study were to 12 
be carried out in a larger sample, those differences may become statistically significant. 13 
Screening can and should occur for everyone who is at an increased risk of malnutrition 14 
using simple tools such as the Malnutrition Screening Tool (MST)(34) or the revised Mini 15 
Nutritional Assessment Short Form (MNA-SF)(35) which require minimal training and are 16 
widely available. If a person is screened at risk of malnutrition, appropriate referrals can be 17 
made to nutrition health care professionals for a full assessment and any subsequent 18 
nutrition care. 19 
Conclusions: 20 
The current study highlights the fact that malnutrition is more prevalent in this group of 21 
people with PD eligible for surgery than it is in the wider PD population and also in 22 
community-dwelling adults. However, this has gone largely unrecognised. The relationships 23 
between appropriate nutrition care, positive health outcomes and lower health care costs in 24 
older adults have been well established.(37) Nutrition support in malnourished patients 25 
undergoing various forms of surgery results in improved surgical outcomes. While the effects 26 
on surgeries such as DBS surgery have not been studied, it is possible that improving 27 
nutritional status prior to DBS may improve post-surgery outcomes.   28 
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